Biotechnology cancer Clinical Trials Pharmaceuticals Leukemia Drug Combo Is Encouraging in Early Phase I Clinical Trial By Staff Reports 3 years ago In a small study, 67 percent of leukemia patients treated with combination of thioguanine and
Biotechnology cancer Treatment Combination To Improve Survival In HER2-Negative Metastatic Breast Cancer By Staff Reports 3 years ago Finding the ideal combination of targeted, hormonal and chemotherapeutic agents to treat HER2-negative metastatic breast
Biotechnology cancer Clinical Trials Immunotherapies New Ovarian Cancer Immunotherapy Study Poses Question: Can Microbiome Influence Treatment Response? By Staff Reports 3 years ago Roswell Park Study with pembrolizumab in untried combination is first ovarian cancer clinical trial to
Biotechnology cancer In Highly Lethal Type Of Leukemia, Cancer Gene Predicts Treatment Response By Staff Reports 3 years ago Patients whose cancer cells carry TP53 mutations respond to milder chemotherapy Patients with the most
Biotechnology cancer New Topical Immunotherapy Effective Against Early Skin Cancer By Staff Reports 3 years ago A combination of two topical drugs that have been in use for years triggers a
cancer Clinical Trials Immunotherapies Experimental CAR-T Treatment Halted as Two More Patients Die During Clinical Trials By Staff Reports 3 years ago Juno Therapeutics said Wednesday it has suspended a Phase II clinical trial of a cancer
Biotechnology cancer Clinical Trials Drug Combination Therapy For Estrogen-Receptor–Positive Breast Cancer Passes Critical Step For Worldwide Approval By Staff Reports 3 years ago Building on earlier clinical trials, UCLA researchers have confirmed that the “breakthrough” drug palbociclib when
Biotechnology cancer Scripps Florida Scientists Create Innovative Drug Design Strategy To Improve Breast Cancer Treatment By Staff Reports 3 years ago While there have been advances in the treatment of hormone-driven breast cancer, resistance to these
Biotechnology cancer T Cell Channel Could Be Targeted to Treat Head and Neck Cancers By Staff Reports 3 years ago Researchers at the University of Cincinnati (UC) have discovered that an ion channel, active within
cancer Cell Therapy TSRI Researchers Show How Circadian ‘Clock’ May Influence Cancer Pathway By Staff Reports 3 years ago A new study led by scientists at The Scripps Research Institute (TSRI) describes an unexpected
cancer Immunotherapies Photo-Bombing Cancer By Staff Reports 3 years ago When Kerstin Stenson, MD, describes the innovative technique she is helping develop to fight cancer,
cancer Cell Therapy Long-Sought Genetic Model Of Common Infant Leukemia Described By Staff Reports 3 years ago After nearly two decades of unsuccessful attempts, researchers from the University of Chicago Medicine and
cancer Accelerating Cancer Research With Deep Learning By Staff Reports 3 years ago Despite steady progress in detection and treatment in recent decades, cancer remains the second leading
Biotechnology cancer The calling card of aggressive thyroid cancer By Staff Reports 3 years ago A new discovery from University of Alberta scientists represents an important milestone in the fight
cancer Cardiology Genomes Heart disease, leukemia linked to dysfunction in nucleus By Staff Reports 3 years ago We put things into a container to keep them organized and safe. In cells, the
cancer NUS Scientists Discover The “Switch” That Makes Breast Cancer Cells Aggressive By Staff Reports 3 years ago A team of scientists from the National University of Singapore (NUS) has established novel insights
cancer Gene Therapy Genomes Hepatitis New Treatment Leaves Liver Cancer Cells In Limbo By Staff Reports 3 years ago Scientists have shown that a mutation in a gene called Arid1b can cause liver cancer.
cancer Genomes Cancer Sequencing Results Differ Based On Genetic Background Of Comparison Genome By Staff Reports 3 years ago When University of Colorado Cancer Center researcher, Jing Hong Wang, MD, PhD, found more than
cancer Cell Therapy Antibody Breaks Leukemia’s Hold, Providing New Therapeutic Approach By Staff Reports 3 years ago Acute myeloid leukemia (AML) is an aggressive cancer known for drug resistance and relapse. In
cancer Cancer Discovery University Of Minnesota Researchers Win Breast Cancer Challenge Award By Staff Reports 3 years ago The University of Minnesota announced today that it is one of two grand prize winners